Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M841Revenue $M68.2Net Margin (%)19.0Z-Score36.7
Enterprise Value $M787EPS $0.5Operating Margin %25.3F-Score4
P/E(ttm))71.0Cash Flow Per Share $0Pre-tax Margin (%)25.8Higher ROA y-yN
Price/Book7.310-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsY
Price/Sales13.65-y EBITDA Growth Rate %0Current Ratio7.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-29.1ROA % (ttm)9.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M32.7ROI % (ttm)22.6Gross Margin Increase y-yN

Gurus Latest Trades with RGEN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RGENJoel Greenblatt 2013-12-31 Buy 0.01%$10 - $13.62
($11.92)
$ 25.71116%New holding, 18532 sh.18,532
RGENGeorge Soros 2006-12-31 Sold Out -0.02%$2.72 - $3.4
($3)
$ 25.71757%Sold Out0
RGENGeorge Soros 2006-03-31 Buy 0.01%$3.62 - $4.89
($4.1)
$ 25.71527%New holding, 105700 sh.105,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RGEN Joel Greenblatt 2014-12-3113,9540.040+8.41%
Premium Most recent portfolio changes are included for Premium Members only!


RGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HERLIHY WALTER CPRESIDENT, CEO 2014-11-19Sell51,386$23.438.58view
RYAN THOMAS F JRDirector 2014-11-13Sell10,000$23.816.85view
Benjamin HowardVP Business Development 2014-11-11Sell30,000$23.567.98view
GRIFFITH MICHAEL ADirector 2014-11-10Sell23,342$22.911.09view
Benjamin HowardVP Business Development 2014-08-13Sell40,000$20.3425.07view
RYAN THOMAS F JRDirector 2014-06-27Sell10,000$22.4113.52view
RYAN THOMAS F JRDirector 2014-06-24Sell10,000$21.7816.8view
HERLIHY WALTER CPRESIDENT, CEO 2014-06-11Sell60,335$20.1126.5view
RUSCHE JAMES RSenior Vice President 2014-06-09Sell30,000$20.1926view
WITT DANIEL PSenior Vice President 2014-06-06Sell47,709$20.5623.74view

Press Releases about RGEN :

    Quarterly/Annual Reports about RGEN:

    News about RGEN:

    Articles On GuruFocus.com
    Repligen Corp. Reports Operating Results (10-Q) Feb 09 2011 
    Repligen Corp. Reports Operating Results (10-Q) Nov 02 2010 
    Repligen Corp. Reports Operating Results (10-Q) Aug 05 2010 
    Repligen Corp. Reports Operating Results (10-Q) Feb 04 2010 
    Repligen Corp. Reports Operating Results (10-Q) Nov 05 2009 
    Repligen Reports First Quarter Fiscal Year 2010 Financial Results Aug 06 2009 
    Repligen Corp. Reports Operating Results (10-Q) Feb 06 2009 

    More From Other Websites
    Repligen Completes Expansion of U.S. Facility Feb 10 2015
    Repligen to Present at 2015 Leerink Global Healthcare Conference Feb 04 2015
    REPLIGEN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement Jan 30 2015
    Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape Jan 26 2015
    REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jan 23 2015
    Repligen Corporation Names Tony Hunt as Next Chief Executive Officer Jan 21 2015
    Repligen Corporation Names Tony Hunt as Next Chief Executive Officer Jan 21 2015
    Repligen Receives Milestone Payment From Pfizer Jan 08 2015
    REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 08 2015
    Repligen Receives Milestone Payment From Pfizer Jan 08 2015
    REPLIGEN CORP Financials Nov 14 2014
    Repligen to Present at Stifel Healthcare Conference 2014 Nov 12 2014
    REPLIGEN CORP Files SEC form 10-Q, Quarterly Report Nov 07 2014
    Repligen posts 3Q profit Nov 06 2014
    Repligen posts 3Q profit Nov 06 2014
    Repligen Reports Third Quarter 2014 Financial Results Nov 06 2014
    REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014
    Repligen to Report Third Quarter 2014 Financial Results Oct 23 2014
    REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial... Aug 18 2014
    REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 11 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK